Richardson, P.G. (2019, June 30). The evolving role of novel and next generation therapies in the management of multiple myeloma: relapse refractory multiple myeloma 2 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved September 22, 2019, from https://hstalks.com/bs/3990/.
Published on June 30, 2019
Advisory board member for: Celgene Corporation, Novartis, Takeda, Oncopeptides, Amgem. Recipient of research funding from: Celgene, Takeda, Oncopeptides, Bristol-Myers Squibb.